In re Am. Bd. of Med. Specialties Maint. of Certification Antitrust Litig.
Opinion
Before the Panel: Plaintiffs in the Mannis action listed on Schedule A move under
On the basis of the papers filed and the hearing held, we conclude that centralization will not serve the convenience of the parties and witnesses or further the just and efficient conduct of this litigation. Where only a minimal number of actions are involved, the proponent of centralization bears a heavier burden to demonstrate that centralization is appropriate. See In re Transocean Ltd. Sec. Litig. (No. II) ,
These actions involve similar allegations that defendants, which offer certification in various medical specialties, require physicians to purchase and participate in "maintenance of certification" programs in order to maintain their initial board certifications. Plaintiffs allege that this constitutes an unlawful tying arrangement in violation of antitrust laws. The similarities, though, end there. Each action names different medical certification boards as defendants, and each is brought on behalf of a different, *1354non-overlapping putative class of physicians.1 Thus, individualized discovery and legal issues (such as with respect to the antitrust market at issue in each action) are likely to be numerous and substantial. Consequently, there is little risk of conflicting pretrial rulings, particularly with respect to class certification.
To the extent these actions may involve duplicative discovery (particularly with respect to ABMS), alternatives to centralization appear eminently feasible. Defendants in the Mannis litigation, which is pending in the Southern District of California, have moved (in the alternative to dismissal) for transfer of that action to the Northern District of Illinois pursuant to
Even if transfer is denied, this litigation involves only four actions pending in three districts, and plaintiffs in three of the actions share counsel. Informal cooperation among the relatively few involved attorneys and coordination among the involved courts therefore are practicable alternatives to centralization. Indeed, defendants represented in their briefs to the Panel their willingness to coordinate with plaintiffs to minimize any potential for duplicative discovery or inconsistent pretrial rulings. See, e.g. , In re Eli Lilly & Co. (Cephalexin Monohydrate) Patent Litig. ,
IT IS THEREFORE ORDERED that the motion for centralization of these actions is denied.
SCHEDULE A
MDL No. 2888 - IN RE: AMERICAN BOARD OF MEDICAL SPECIALTIES MAINTENANCE OF CERTIFICATION ANTITRUST LITIGATION
Southern District of California
MANNIS, ET AL. v. AMERICAN BOARD OF MEDICAL SPECIALTIES, ET AL., C.A. No. 3:19-00341
Northern District of Illinois
SIVA v. AMERICAN BOARD OF RADIOLOGY, C.A. No. 1:19-01407
Eastern District of Pennsylvania
KENNEY, ET AL. v. AMERICAN BOARD OF INTERNAL MEDICINE, C.A. No. 2:18-05260
Footnotes
Free access — add to your briefcase to read the full text and ask questions with AI
382 F. Supp. 3d 1353 (In re Am. Bd. of Med. Specialties Maint. of Certification Antitrust Litig.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.